{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:16:26Z","timestamp":1740104186096,"version":"3.37.3"},"reference-count":10,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1002\/ajh.25054","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T01:46:45Z","timestamp":1517622405000},"source":"Crossref","is-referenced-by-count":1,"title":["Current and potential use of pathological targets in the treatment of <scp>H<\/scp>odgkin lymphoma"],"prefix":"10.1002","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-639X","authenticated-orcid":false,"given":"Antonino","family":"Carbone","sequence":"first","affiliation":[{"name":"Department of Pathology Centro di Riferimento Oncologico Aviano (CRO) Istituto Nazionale Tumori, IRCCS Aviano Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annunziata","family":"Gloghini","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Laboratory Medicine Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"e_1_2_1_5_2_1","first-page":"424","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Stein H","year":"2017"},{"key":"e_1_2_1_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2711"},{"key":"e_1_2_1_5_4_1","unstructured":"IARC.Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens Part B: Biological Agents\/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Vol. 100. Lyon: IARC;2012."},{"key":"e_1_2_1_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8401"},{"key":"e_1_2_1_5_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-734541"},{"key":"e_1_2_1_5_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2016.05.011"},{"key":"e_1_2_1_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-787200"},{"key":"e_1_2_1_5_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.317"},{"journal-title":"CA Cancer J Clin.","article-title":"Hodgkin lymphoma: a review and update on recent progress","author":"Shanbhag S","key":"e_1_2_1_5_10_1"},{"key":"e_1_2_1_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4558"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.25054","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.25054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T04:06:46Z","timestamp":1694318806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.25054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1002\/ajh.25054"],"URL":"https:\/\/doi.org\/10.1002\/ajh.25054","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"type":"print","value":"0361-8609"},{"type":"electronic","value":"1096-8652"}],"subject":[],"published":{"date-parts":[[2018,2,14]]}}}